Product Information
17496-1-AP targets TAZ; tafazzin in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11631 Product name: Recombinant human TAZ; tafazzin protein Source: e coli.-derived, T-HIS Tag: 6*His Domain: 1-262 aa of BC011515 Sequence: MPLHVKWPFPAVPPLTWTLASSVVMGLVGTYSCFWTSEWAQAEAGPPGYPCPAGGILKLRHIWNLKLMRWTPAAADICFTKELHSHFFSLGKCVPVCRGDGVYQKGMDFILEKLNHGDWVHIFPEGIGRLIAECHLNPIILPLWHVGEPGDGDREMASGVGGLGLPLVPGCPAPPHVWPSVHCAAGMNDVLPNSPPYFPRFGQKITVLIGKPFSALPVLERLRAENKSAVEMRKALTDFIQEEFQHLKTQAEQLHNHLQPGR Predict reactive species |
| Full Name | tafazzin |
| Calculated Molecular Weight | 262 aa, 29 kDa |
| GenBank Accession Number | BC011515 |
| Gene Symbol | TAZ |
| Gene ID (NCBI) | 6901 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q16635 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The TAZ (tafazzin) polyclonal antibody (Cat# 17496-1-AP) has 2 citations. They appear in Journal of Ethnopharmacology and Biochemical and Biophysical Research Communications. The research fields cover autoimmune myasthenia gravis and regulatory T cell immunosuppression via the Hippo pathway, as well as osteoclastogenesis inhibition and ovariectomy-induced bone loss, both involving TAZ activation in the Hippo signaling cascade.
| Species | Application | Title |
|---|---|---|
J Ethnopharmacol ShengXian Decoction alleviates experimental autoimmune myasthenia gravis by enhancing the immunosuppressive activity of Regulatory T cells via Hippo pathway | ||
Biochem Biophys Res Commun Activation of TAZ by XMU-MP-1 inhibits osteoclastogenesis and attenuates ovariectomy-induced cancellous bone loss |
